• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cassava Sciences Inc (NQ: SAVA )

    28.48 -3.39 (-10.62%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 5,779,168
    Open 28.08
    Bid (Size) 28.35 (7)
    Ask (Size) 28.40 (1)
    Prev. Close 31.87
    Today's Range 26.10 - 30.33
    52wk Range 8.790 - 42.20
    Shares Outstanding 41,969,994
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Cassava Sciences Unusual Options Activity
    Via Benzinga
    Cassava Sciences, enVVeno Medical And Other Big Stocks Moving Lower In Friday's Pre-Market Session
    Via Benzinga

    Performance

    YTD
    +27.05%
    +27.05%
    1 Month
    -1.13%
    -1.13%
    3 Month
    +50.32%
    +50.32%
    6 Month
    +40.39%
    +40.39%
    1 Year
    +68.05%
    +68.05%

    More News

    Read More
    SEC Charges Cassava Sciences Over Manipulated Alzheimer's Trial Data, Company And Former Execs Agree To Pay Penalty
    Via Benzinga
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Why Establishment Labs Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Here's How Much $100 Invested In Cassava Sciences 5 Years Ago Would Be Worth Today
    Via Benzinga
    Market Whales and Their Recent Bets on SAVA Options
    Via Benzinga
    Cassava Sciences Resolves SEC Investigation
    From Cassava Sciences, Inc.
    Via GlobeNewswire
    Cassava Sciences Stock Rises On Interim Safety Review Of Simufilam Phase 3 Trials
    Via Benzinga
    Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
    From Cassava Sciences, Inc.
    Via GlobeNewswire
    Cassava Sciences Names Rick Barry as Chief Executive Officer
    From Cassava Sciences, Inc.
    Via GlobeNewswire
    What's Going On With Cassava Sciences Today?
    Via Benzinga
    (SAVA) - Analyzing Cassava Sciences's Short Interest
    Via Benzinga
    Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference
    From Cassava Sciences, Inc.
    Via GlobeNewswire
    9 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
    Via MarketBeat
    SAVA Stock Earnings: Cassava Sciences Beats EPS for Q2 2024
    Via InvestorPlace
    Cassava Sciences Reports Q2 2024 Financial Results and Operational Updates
    From Cassava Sciences, Inc.
    Via GlobeNewswire
    What's Going On With Cassava Sciences Shares Today?
    Via Benzinga
    Cassava Sciences News: Why Is SAVA Stock Trending Today?
    Via InvestorPlace
    Cassava Sciences Mourns the Death of Board Member Sanford “Sandy” Robertson
    From Cassava Sciences, Inc.
    Via GlobeNewswire
    Cassava Sciences Shares Are Trading Higher Today: What You Need To Know
    Via Benzinga
    Get Your Money Out of These 3 Healthcare Stocks ASAP
    Via InvestorPlace
    8 Best-Performing Small Caps In July: Find Out Which Stock Jumped 803%
    Via Benzinga
    Cassava Sciences to Hold Conference Call to Discuss Recent Developments and Provide a Company Update on Thursday, August 8, 2024 at 8:30 am ET
    From Cassava Sciences, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.